# A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women

> **NCT00915668** · PHASE1 · WITHDRAWN · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.**

## Conditions studied

- Pharmacokinetics
- Drug Interactions
- Healthy

## Interventions

- **DRUG:** JNJ-31001074

## Key facts

- **NCT ID:** NCT00915668
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2011-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The trial is postponed pending the completion of other ongoing pre-clinical and clinical work.
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915668, "A Study to Evaluate the Pharmacokinetic Drug Interaction Between Multiple Doses of JNJ-31001074 and a Single Dose of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00915668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*